Evidence map›Paper›PMID 41261915›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025

Deazaalloxazines - Flavin Derivatives That Provide Reductive Photoredox Catalysis with Inert Substrates.

Ivana Weisheitelová, Naisargi Varma, Ludmila Šimková, Josef Chudoba, Tetiana Pavlovska, Iwona Gulaczyk, Gotard Burdziński, Jiří Ludvík, Marek Sikorski, Radek Cibulka

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Flavin Catalysts in Organic Synthesis.Angewandte Chemie (International ed. in English) · 2026
    Review
  2. Article
  3. Article
  4. Photophysical properties and acid-base equilibria of lumichrome anions in nonaqueous media.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  5. Molecules (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ivana WeisheitelováDepartment of Organic Chemistry, University of Chemistry and Technology, Prague, Technická 5, Prague, 16628, Czech Republic.ORCID https://orcid.org/0000-0002-3578-7582
Naisargi VarmaFaculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego 8, Poznań, 61-614, Poland.ORCID https://orcid.org/0000-0002-1760-5458
Ludmila ŠimkováDepartment of Molecular Electrochemistry and Catalysis, J. Heyrovský Institute of Physical Chemistry, Czech Academy of Sciences, Dolejškova 3, Prague, 18223, Czech Republic.ORCID https://orcid.org/0000-0003-2655-2148
Josef ChudobaCentral Laboratories, University of Chemistry and Technology, Prague, Technická 5, Prague, 16628, Czech Republic.ORCID https://orcid.org/0000-0003-4127-0376
Tetiana PavlovskaDepartment of Organic Chemistry, University of Chemistry and Technology, Prague, Technická 5, Prague, 16628, Czech Republic.ORCID https://orcid.org/0000-0002-3540-5863
Iwona GulaczykFaculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego 8, Poznań, 61-614, Poland.ORCID https://orcid.org/0000-0002-8714-6242
Gotard BurdzińskiFaculty of Physics and Astronomy, Adam Mickiewicz University, Uniwersytetu Poznańskiego 2, Poznań, 61-614, Poland.ORCID https://orcid.org/0000-0002-2947-1602
Jiří LudvíkDepartment of Molecular Electrochemistry and Catalysis, J. Heyrovský Institute of Physical Chemistry, Czech Academy of Sciences, Dolejškova 3, Prague, 18223, Czech Republic.ORCID https://orcid.org/0000-0003-1902-7097
Marek SikorskiFaculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego 8, Poznań, 61-614, Poland.ORCID https://orcid.org/0000-0002-9527-7322
Radek CibulkaDepartment of Organic Chemistry, University of Chemistry and Technology, Prague, Technická 5, Prague, 16628, Czech Republic.ORCID https://orcid.org/0000-0002-8584-7715

Funding

Grantová Agentura České Republiky 23-06465SGrantová Agentura České Republiky 24-11386KNarodowe Centrum Nauki 2020/02/Y/ST4/00042Narodowe Centrum Nauki 2023/05/Y/ST4/00062
6 · The paper itself

Abstract

Reductive transformations of substances that are difficult to reduce continue to pose challenges for photoredox catalysis. Promising photoreduction catalysts include flavin and deazaflavin derivatives; however, even their reductive abilities are limited for the range of substrates considered "inert". In this work, we present 5-deazaalloxazines, a new group of deazaflavin analogues that are predisposed to catalyze reductions due to their low reduction potential (down to -1.65 V vs. SCE) even in the ground state. We studied three series of 5-deazaalloxazines ([i] 5-unsubstituted, [ii] 5-aryldeazaalloxazines, and [iii] 5-trifluoromethyl-5-deazaalloxazines) to determine their photophysical and electrochemical properties and their ability to participate in model photoreduction reactions. From 31 compounds, we selected 1,3-dimethyl-7,8-dimethoxy-5-(o-tolyl)-5-deazaalloxazine [3a(o-MePh)], as it showed, among other things, the highest efficiency in photodehalogenation of p-fluoroanisole and was photostable and absorbed in the visible light region, thereby allowing photoreactions using a 400 nm LED. Practical applicability was demonstrated in the C─P coupling reaction of electron-rich aryl halides (including chloroanisoles and p-fluoroanisole) with trimethyl phosphite, providing an arylation reaction to form dimethyl arylphosphonates, and in the release/deprotection of amines from the corresponding tosyl and triflylamides.

Indexed as

cross‐couplingcyclic voltammetrydeprotectionphotoredox catalysisreductionspectroscopy

Identifiers

PMID41261915
PMCPMC12734692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.